Understanding the Latest COVID Variant: Nimbus and Its Unique Symptom

মন্তব্য · 22 ভিউ

The COVID-19 Nimbus variant is on the rise in the U.S. as many report a painful symptom known as "razor blade throat." If you have a severe sore throat, it's important to rule out strep throat to avoid severe complications. COVID-19 precautions like masking and vaccination remain important.

As the COVID-19 Nimbus variant gains traction in the U.S., a new symptom known as 'razor blade throat' is causing concern among individuals. It's crucial to differentiate between this symptom and strep throat to prevent serious complications. Adhering to COVID-19 safety measures like wearing masks and getting vaccinated remains essential.

Distinct Characteristics of Nimbus Variant

Initial data indicates that Nimbus may not lead to more severe illness overall, but the emergence of intense sore throats has raised questions about how this variant differs from previous ones. While sore throat has been a recognized COVID-19 symptom, the specific sensation of 'razor blade throat' associated with Nimbus sets it apart.

Overview of Nimbus Variant

The newly identified COVID-19 variant, Nimbus or NB.1.8.1, is a subvariant of the Omicron strain of the SARS-CoV-2 virus responsible for COVID-19. Dr. Scott Roberts from Yale School of Medicine revealed that Nimbus currently comprises approximately one-third of COVID-19 cases in the U.S. He explained that the variant's increased transmissibility is attributed to mutations in the spike protein, distinguishing it from other variants.

Expert Insights on Nimbus

Dr. Kartik Cherabuddi, Chief Hospital Epidemiology Officer at Tampa General Hospital, highlighted that while Nimbus is rapidly spreading globally, its public health threat remains relatively low compared to other Omicron lineages. Early laboratory findings suggest that Nimbus does not exhibit significant immune evasion capabilities or heightened resistance to antiviral treatments. However, there is currently a lack of studies on how Nimbus impacts clinical outcomes.



Source: Healthline
মন্তব্য